Lorem ipsum dolor
Lorem ipsum dolor
Lorem ipsum dolor
• Lorem ipsum dolor sit amet, consectetuer adipiscing elit. • Pellentesque egestas iaculis tellus.
• Nunc id quam ut nunc placerat mollis.
• Mauris euismod feugiat mi.
Pellentesque egestas
0
5
10
15
20
25
HaCat A549
Control
F-Ara
F-Arad
Presentation Title
Presenter and Affiliation
Welcome and Introductions
Lorem Ipsum
Break
Lorem Ipsum
Break
Lorem Ipsum
Lunch
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Contents
Bullet Slide
• Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
• Pellentesque egestas iaculis tellus.
• Nunc id quam ut nunc placerat mollis.
• Mauris euismod feugiat mi.
Figure Slide
EATEAI EAD
Exercise Title
• Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
• Pellentesque egestas iaculis tellus.
• Nunc id quam ut nunc placerat mollis.
• Mauris euismod feugiat mi.
Review Title
Open / General
Closed / Specific
Chapter Heading
Sub Chapter Heading
For internal use only Issue 1: aug 2002
H next
Bonefos SymposiumChaired by:
Professor John A Kanis
World Health Organisation Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield, UK
Sponsor: Leiras, subsidiary of Schering AG
12 April 2002Arktikum CentreRovaniemi, Lapland
For internal use only
Issue 1aug 2002
A major player in long-term osteoprotection
Bonefos Global Strategy
BONEFOS
PROSTATECANCER
BREASTCANCER
MULTIPLEMYELOMA
Clinical efficacy and tolerability of oral Bonefos in long-term use
back
next
For internal use only
Issue 1aug 2002
Enduring Materials
Bonefos symposium highlight report: New Insights into Bonefos Therapy
Timeline: to be available by (To be determined)Cost: (To be determined) per copyOrdering: (To be determined)
back